| 文章作者： | Ellen Werber Leschek, Susan R. Rose, Jack A. Yanovski, James F. Troendle, Charmian A. Quigley, John J. Chipman, Brenda J. Crowe, Judith L. Ross, Fernando G. Cassorla, Werner F. Blum, Gordon B. Cutler, Jr. and Jeffrey Baron
(on behalf of the National Institute of Child Health Human Development-Eli Lilly and Company Growth Hormone Collaborative Group) |
| 作者单位： | Developmental Endocrinology Branch (E.W.L., J.A.Y., J.B.) and Biometry and Mathematical Statistics Branch (J.F.T.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; Department of Endocrinology (S.R.R.), Children’s Hospital Medical Center, Cincinnati, Ohio 45229; Eli Lilly and Company (C.A.Q., J.J.C., B.J.C., W.F.B., G.B.C.), Indianapolis, Indiana 46285; Department of Pediatrics (J.L.R.), Thomas Jefferson University, Philadelphia, Pennsylvania 19107; Alfred I. duPont Hospital for Children (J.L.R.), Wilmington, Delaware 19899; and Institute of Maternal and Child Research (F.G.C.), University of Chile, Santiago, Chile |